Etoposide as the basic and interferon-α as the maintenance therapy for Langerhans cell histiocytosis: A RTC

Pediatric Hematology and Oncology

Volumn 18, Issue 4, 2001, Pages 291-294

  Culi, S ^a   Jakobson, A ^b   Culi, V ^a   Kuzmi, I ^a   Sukanec Spoljar, M ^c   Primorac, A ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

^c KBC Zagreb   (Croatia)

Author keywords

Etoposide; INF ; Langerhans cell histiocytosis

Indexed keywords

ALPHA INTERFERON; ETOPOSIDE; PROTEIN S 100;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; ELECTRON MICROSCOPY; FEMALE; HIGH RISK PATIENT; HISTIOCYTOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LANGERHANS CELL; MAINTENANCE THERAPY; PREDICTION; PRESCHOOL CHILD; PROGNOSIS; PROTEIN ANALYSIS;

ANTIBODIES, VIRAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; ETOPOSIDE; FEMALE; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; INTERFERON-ALPHA; REMISSION INDUCTION; S100 PROTEINS;

EID: 0034982035     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800101750238612     Document Type: Article

References (10)

1. Langerhans cell histiocytosis
2. The normal Langerhans cell and the LCH cell
3. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis
4. Viruses and Langerhans cell histiocytosis: Is there a link?
5. Etoposide (VP-16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X)
6. LCH I: A randomized trial for multisystem Langerhans cell histiocytosis
7. Treatment of Langerhans Cell histiocytosis with alpha-interferon
8. Histiocytosis X: Successful treatment with recombinant interferon-alfa A
9. Histiocytosis syndromes in children
10. Etoposide in recurrent childhood Langerhans' cell histiocytosis: An Italian cooperative study